Setrobuvir (RO-5466731; ANA-598) is a novel, oral and potent HCV NS5B polymerase inhibitor which inhibits both de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. Setrobuvir also shows excellent binding affinity to SARS-CoV-2 RdRp and induces RdRp inhibition.

纯度：≥98%

CAS：1071517-39-9